Finland – Pharmaceutical products – Various pharmaceutical products for rescEU Medical -project
Issued by Finnish Institute for Health and Welfare · via TED — Tenders Electronic Daily (EU)
- Published
- 16 Nov 2026
- Closes
- 21 Dec 2026, 23:59 UTC
- Reference
- 795969-2026
- Location
- Finland
- Sector
- Healthcare & Pharma
- Type
- goods
At a glance
Finnish Institute for Health and Welfare in Finland has published an invitation to bid in healthcare & pharma: “Finland – Pharmaceutical products – Various pharmaceutical products for rescEU Medical -project”. Submissions close on 21 December 2026, 36 days from today. Quote reference 795969-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 3 notices from this buyer since 2026, 2 of them currently open. There are 39 open healthcare & pharma notices in Finland on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on EU public procurement
Most EU buyers ask for the European Single Procurement Document (ESPD) as a self-declaration with the bid. Submission is on the e-procurement platform named in the notice.
Details
Finnish Institute for Health and Welfare, later referred to as THL or Customer, request your tender for various pharmaceutical products to the rescEU Medical -project. The Scope of procurement is described in more detail in the Annex 1. The procurement is divided in ten (10) lots. Each Article constitutes a separate lot. Tender may be submitted for one or several lots. LOT 1: Electrolytes (ringer's solution) 1000 ml (intravenous infusion, ATC B05BB01) LOT 2: Electrolytes with carbohydrates 50 mg/ml (500 ml, solution for infusion, ATC B05BB02) LOT 3: Esketamine 25 mg/ml (2 ml, solution for injection/infusion, ATC N01AX14) LOT 4: Oxycodone 10 mg/ml (1 ml, solution for injection, ATC N02AA05) LOT 5: Oxycodone 10 mg/ml (10 ml, solution for injection, ATC N02AA05) LOT 6: Levetiracetam 100 mg/ml (5 ml, concentrate for solution for infusion, ATC N03AX14) LOT 7: Cefuroxime 1500 mg (powder for solution for injection, ATC J01DC02) LOT 8: Vancomycin 1000 mg (powder for solution for injection, ATC J01XA01) LOT 9: Enoxaparin 100 mg/ml (1 ml, sub-cutaneous, ATC B01AB05) LOT 10: Tranexamic acid 100 mg/ml (10 ml, intra muscular/intravenous, ATC B02AA02) The tender shall consist of one (1) Article for each tendered lot. The minimum requirements for the Article is described in the Annex 1.1. The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed. Quantity for the Articles is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of December 2028 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. Call for tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Contract draft Annex 3 Security annex Annex 4 JYSE 2025 SUPPLIES Annex 5 Confidentiality commitment Annex 6 Quantity of the Articles (restricted, TL IV) Please note that the numbering of the annexes differs between the Contract draft and the Call for tenders. The numbering of the Annexes to the Contract draft is based on the order of precedence applied in the Contract.
Lots Lot 1 — LOT 1: Electrolytes (ringer's solution) 1000 ml (intravenous infusion, ATC B05BB01): The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Electrolytes (ringer's solution) 1000 ml (intravenous infusion, ATC B05BB01) - Active pharmaceutical ingredient: Electrolytes (ringer's solution) - Container size: 1000 ml - Pharmaceutical form: intravenous infusion - ATC code: B05BB01 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU). Lot 2 — LOT 2: Electrolytes with carbohydrates 50 mg/ml (500 ml, solution for infusion, ATC B05BB02): The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Electrolytes with carbohydrates 50 mg/ml (500 ml, solution for infusion, ATC B05BB02) - Active pharmaceutical ingredient: Electrolytes with carbohydrates - Strength: 50 mg/ml - Container size: 500 ml - Pharmaceutical form: solution for infusion - ATC code: B05BB02 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU). Lot 3 — LOT 3: Esketamine 25 mg/ml (2 ml, solution for injection/infusion, ATC N01AX14): The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Esketamine 25 mg/ml (2 ml, solution for injection/infusion, ATC N01AX14) - Active pharmaceutical ingredient: Esketamine - Strength: 25 mg/ml - Container size: 2 ml - Pharmaceutical form: solution for injection/infusion, vial/ampoule - ATC code: N01AX14 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU). Lot 4 — LOT 4: Oxycodone 10 mg/ml (1 ml, solution for injection, ATC N02AA05): The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Oxycodone 10 mg/ml (1 ml, solution for injection, ATC N02AA05) - Active pharmaceutical ingredient: Oxycodone - Strength: 10 mg/ml - Container size: 1 ml - Pharmaceutical form: solution for injection, vial/ampoule - ATC code: N02AA05 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU). Lot 5 — LOT 5: Oxycodone 10 mg/ml (10 ml, solution for injection, ATC N02AA05): The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Oxycodone 10 mg/ml (10 ml, solution for injection, ATC N02AA05) - Active pharmaceutical ingredient: Oxycodone - Strength: 10 mg/ml - Container size: 10 ml - Pharmaceutical form: solution for injection, vial/ampoule - ATC code: N02AA05 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU). Lot 6 — LOT 6: Levetiracetam 100 mg/ml (5 ml, concentrate for solution for infusion, ATC N03AX14): The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Levetiracetam 100 mg/ml (5 ml, concentrate for solution for infusion, ATC N03AX14) - Active pharmaceutical ingredient: Levetiracetam - Strength: 100 mg/ml - Container size: 5 ml - Pharmaceutical form: concentrate for solution for infusion, vial - ATC code: N03AX14 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU). Lot 7 — LOT 7: Cefuroxime 1500 mg (powder for solution for injection, ATC J01DC02): The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Cefuroxime 1500 mg (powder for solution for injection, ATC J01DC02) - Active pharmaceutical ingredient: Cefuroxime - Strength: 1500 mg - Pharmaceutical form: powder for solution for injection, vial - ATC code: J01DC02 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU). Lot 8 — LOT 8: Vancomycin 1000 mg (powder for solution for injection, ATC J01XA01): The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Vancomycin 1000 mg (powder for solution for injection, ATC J01XA01) - Active pharmaceutical ingredient: Vancomycin - Strength: 1000 mg - Pharmaceutical form: powder for solution for injection, vial - ATC code: J01XA01 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU). Lot 9 — LOT 9: Enoxaparin 100 mg/ml (1 ml, sub-cutaneous, ATC B01AB05): The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Enoxaparin 100 mg/ml (1 ml, sub-cutaneous, ATC B01AB05) - Active pharmaceutical ingredient: Enoxaparin - Strength: 100 mg/ml - Container size: 1 ml - Pharmaceutical form: sub-cutaneous, pre-filled syringe - ATC code: B01AB05 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU). Lot 10 — LOT 10: Tranexamic acid 100 mg/ml (10 ml, intra muscular/intravenous, ATC B02AA02): The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Tranexamic acid 100 mg/ml (10 ml, intra muscular/intravenous, ATC B02AA02) - Active pharmaceutical ingredient: Tranexamic acid - Strength: 100 mg/ml - Container size: 10 ml - Pharmaceutical form: intra muscular/intravenous, vial/ampoule - ATC code: B02AA02 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Buyer: Finnish Institute for Health and Welfare
Buyer country: FIN
Procedure: open
CPV code: 33600000
Full notice, tender documents and how to bid are on the official TED page (link above).
Context for bidders
We hold 3 notices from Finnish Institute for Health and Welfare, going back to September 2026 — 2 of them still open. They buy mostly in Defence & Security, Healthcare & Pharma and Financial & Professional Services. There are 39 open Healthcare & Pharma tenders in Finland. This one closes in 36 days.
More from this buyer
Similar Healthcare & Pharma tenders
- Finland – Medical consumables – Haavanhoidon ja ensiavun tarvikkeet· closes 18 Dec
- Finland – Medical equipments, pharmaceuticals and personal care products – TP40/26EU Suojaus ja peittelytarvikkeet, Leikkausympäristön ja potilaan suojaus· closes 18 Dec
- Finland – Blood and fluid warming – PSHVA-0068-2026 Veren- ja nesteenlämmittimet· closes 10 Dec
- Finland – Medical equipments, pharmaceuticals and personal care products – KESKEYTETTY Asentotuet· closes 27 Nov
- Finland – Medical equipments, pharmaceuticals and personal care products – Ortopediset jalkineet ja tukipohjalliset· closes 7 Dec
Explore Finland
Documents
- TED-official-notice-795969-2026.pdfDownload (pdf)
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Поставка лекарственных препаратовФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ ЦЕНТР СЕРДЕЧНО-СОСУДИСТОЙ ХИРУРГИИ ИМЕНИ С.Г. СУХАНОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (Г. ПЕРМЬ) · Russia
- Поставка сывороток животного происхожденияГОСУДАРСТВЕННЫЙ КОМИТЕТ ПО РЕГУЛИРОВАНИЮ КОНТРАКТНОЙ СИСТЕМЫ В СФЕРЕ ЗАКУПОК РЕСПУБЛИКИ ХАКАСИЯ · Russia
- Оказание медицинских услуг (Спермограмма)ГОСУДАРСТВЕННЫЙ КОМИТЕТ ПО РЕГУЛИРОВАНИЮ КОНТРАКТНОЙ СИСТЕМЫ В СФЕРЕ ЗАКУПОК РЕСПУБЛИКИ ХАКАСИЯ · Russia
- Поставка лекарственного препарата для медицинского применения в пользу граждан в целях их социального обеспечения РЛО+ФЛО (КЕТОПРОФЕН) в 2027 годуГОСУДАРСТВЕННЫЙ КОМИТЕТ ПО РЕГУЛИРОВАНИЮ КОНТРАКТНОЙ СИСТЕМЫ В СФЕРЕ ЗАКУПОК РЕСПУБЛИКИ ХАКАСИЯ · Russia
- Поставка лекарственного препарата для медицинского применения в пользу граждан в целях их социального обеспечения РЛО+ФЛО (ДЕКСАМЕТАЗОН) в 2027 годуГОСУДАРСТВЕННЫЙ КОМИТЕТ ПО РЕГУЛИРОВАНИЮ КОНТРАКТНОЙ СИСТЕМЫ В СФЕРЕ ЗАКУПОК РЕСПУБЛИКИ ХАКАСИЯ · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →